FiercePharmaOriginal article
{"a":[{"_":"Fresenius pulls one batch of Actemra biosim over glass particle concerns","$":{"href":"/pharma/fresenius-pulls-one-batch-actemra-biosim-over-glass-particle-concerns","hreflang":"en"}}]}
RegulatoryActemra biosimNegative
AI Analysis
Summary
Fresenius Kabi is recalling a batch of Actemra biosim in the U.S. due to glass particle concerns, following a separate recall of mislabeled pain medicine.
Outcome Details
Batch recall due to glass particle concerns
Importance:4/10
Sentiment:
-0.70
product recallsafety concernglass particlesbiosimilarmanufacturing issue
Related Companies
Read the original article
Published by FiercePharma on August 12, 2026 8:42 AM
